GIM believes that a benchmark-agnostic portfolio of international American Depository Receipts (ADRs), constructed with a disciplined blend of proprietary multi-factor models and downside risk screens, may achieve long-term performance.
The competitive advantage of our International ADR strategy is derived from the following key attributes:
Quantitative discipline; fundamental insight
Models based on intuitive fundamentals that drive performance
Proprietary, diversified models for each country and sector
Unique models for buying and selling
Initial equal weighting vs. weighting by market cap
Minimizes single-stock risk; avoids bias toward expensive ADRs
Discipline emphasizes high quality and valuation
Potential for superior upside and downside capture
Summary Investment Guidelines
- Universe: MSCI World, ex U.S.
- Benchmark: MSCI World, ex U.S.
- 70-120 holdings
- Initial position maximum: 1%
- Existing position maximum: 3% for any security
- Sector: +/–5% vs. MSCI World, ex U.S.
|As of 3/31/2021||QTD||YTD||1 YEAR||3 YEAR||5 YEAR||10 YEAR||Since Inception||Inception Date|
|Quantitative International ADR Equity (Gross)||5.4%||5.4%||43.4%||3.0%||6.6%||3.8%||7.0%||11/30/1988|
|Quantitative International ADR Equity (Net)||5.2%||5.2%||42.3%||2.2%||5.8%||2.9%||6.5%|
|MSCI World x US/MSCI EAFE*||4.0%||4.0%||45.9%||6.1%||8.9%||5.5%||4.9%|
Calendar Year Returns
|Glenmede Gross||Glenmede Net||MSCI World x US/MSCI EAFE*||Gross +/-|
*The Blended Benchmark consists of the MSCI EAFE from inception through 2/28/2020 and the MSCI World ex US thereafter. Prior to 03/01/2020, the benchmark shown was the MSCI EAFE. The MSCI World ex US benchmark is the equivalent of the MSCI EAFE plus Canada. This change improves potential diversification which is expected to improve alpha opportunity and tracking error. The MSCI World ex US Index is a free float-adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the US. The MSCI World ex US Index consists of the following 22 developed market country indices: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, and the UK. One cannot invest directly in an index. The MSCI EAFE Index is a group of unmanaged securities widely regarded by investors to be representative of the stock markets of Europe, Australia, and the Far East. The Index is a total return index net of foreign withholding taxes on dividends. MSCI EAFE Index is an equity index which captures large and mid-cap representation across Developed Markets countries* around the world, excluding the US and Canada. *Developed Markets countries in the MSCI EAFE Index include: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the UK. One cannot invest directly in an index. Source: MSCI. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indexes or any securities or financial products. This report is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
This website is for informational purposes only and is not a solicitation for any product or service. GIM products are actively managed and their characteristics will vary. All investment has risk, including the risk of loss of principal. There can be no assurance that efforts to manage risk or to achieve any articulated investment objective will be successful. An investor should consider investment objectives, risks, charges and expenses carefully before investing. For additional information regarding risks and about the firm, please refer to Related Literature and Disclosures.